CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 42 filers reported holding CATALYST BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,448 | -73.2% | 5,079 | -80.5% | 0.00% | – |
Q2 2023 | $9,146 | -34.7% | 25,983 | +238.2% | 0.00% | – |
Q2 2022 | $14,000 | +180.0% | 7,682 | +47.6% | 0.00% | – |
Q4 2021 | $5,000 | -54.5% | 5,205 | +99.5% | 0.00% | – |
Q2 2021 | $11,000 | -73.2% | 2,609 | -67.5% | 0.00% | – |
Q1 2021 | $41,000 | +10.8% | 8,039 | +36.9% | 0.00% | – |
Q4 2020 | $37,000 | +1750.0% | 5,872 | +991.4% | 0.00% | – |
Q3 2020 | $2,000 | -99.8% | 538 | -99.7% | 0.00% | – |
Q2 2020 | $944,000 | +23500.0% | 160,665 | +14694.2% | 0.00% | – |
Q1 2020 | $4,000 | -84.6% | 1,086 | -71.6% | 0.00% | – |
Q4 2019 | $26,000 | +225.0% | 3,826 | +121.4% | 0.00% | – |
Q3 2019 | $8,000 | +700.0% | 1,728 | +1415.8% | 0.00% | – |
Q2 2019 | $1,000 | -95.0% | 114 | -95.4% | 0.00% | – |
Q1 2019 | $20,000 | -74.4% | 2,483 | -74.8% | 0.00% | – |
Q4 2018 | $78,000 | -15.2% | 9,837 | +15.1% | 0.00% | – |
Q3 2018 | $92,000 | +17.9% | 8,546 | +27.9% | 0.00% | – |
Q2 2018 | $78,000 | +129.4% | 6,684 | +413.4% | 0.00% | – |
Q1 2018 | $34,000 | -89.9% | 1,302 | -94.7% | 0.00% | – |
Q4 2017 | $338,000 | +174.8% | 24,747 | +1.7% | 0.00% | – |
Q3 2017 | $123,000 | +0.8% | 24,345 | -7.0% | 0.00% | – |
Q2 2017 | $122,000 | -47.0% | 26,169 | +7.5% | 0.00% | – |
Q1 2017 | $230,000 | – | 24,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |